These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 21394301)

  • 41. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.
    Liu FH; Kuo SF; Hsueh C; Chao TC; Lin JD
    J Surg Oncol; 2015 Aug; 112(2):149-54. PubMed ID: 26175314
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intratumoural lymph vessel density is related to presence of lymph node metastases and separates encapsulated from infiltrative papillary thyroid carcinoma.
    Eloy C; Santos J; Soares P; Sobrinho-Simões M
    Virchows Arch; 2011 Dec; 459(6):595-605. PubMed ID: 22081104
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tumor genotype determines phenotype and disease-related outcomes in thyroid cancer: a study of 1510 patients.
    Yip L; Nikiforova MN; Yoo JY; McCoy KL; Stang MT; Armstrong MJ; Nicholson KJ; Ohori NP; Coyne C; Hodak SP; Ferris RL; LeBeau SO; Nikiforov YE; Carty SE
    Ann Surg; 2015 Sep; 262(3):519-25; discussion 524-5. PubMed ID: 26258321
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Implication of minimal extrathyroidal extension as a prognostic factor in papillary thyroid carcinoma.
    Shin JH; Ha TK; Park HK; Ahn MS; Kim KH; Bae KB; Kim TH; Choi CS; Kim TK; Bae SK; Kim SH
    Int J Surg; 2013; 11(9):944-7. PubMed ID: 23820062
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vascular invasion is an independent prognostic factor for distant recurrence-free survival in papillary thyroid carcinoma: a matched-case comparative study.
    Cao J; Hu JL; Chen C; Wang QL; Fang XH; Zhang Y; Ge MH
    J Clin Pathol; 2016 Oct; 69(10):872-7. PubMed ID: 27010434
    [TBL] [Abstract][Full Text] [Related]  

  • 46. REGγ Is Associated with Lymph Node Metastasis and T-Stage in Papillary Thyroid Carcinoma.
    Qi L; He W
    Med Sci Monit; 2018 Mar; 24():1373-1378. PubMed ID: 29509725
    [TBL] [Abstract][Full Text] [Related]  

  • 47. BRAF(V600E) mutation in Turkish patients with papillary thyroid cancer: strong correlation with indicators of tumor aggressiveness.
    Kurtulmus N; Duren M; Ince U; Cengiz Yakicier M; Peker O; Aydın O; Altiok E; Giray S; Azizlerli H
    Endocrine; 2012 Oct; 42(2):404-10. PubMed ID: 22426956
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predictive factors of contralateral paratracheal lymph node metastasis in unilateral papillary thyroid carcinoma.
    Wei T; Chen R; Zou X; Liu F; Li Z; Zhu J
    Eur J Surg Oncol; 2015 Jun; 41(6):746-50. PubMed ID: 25882035
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Restratification of survival prognosis of N1b papillary thyroid cancer by lateral lymph node ratio and largest lymph node size.
    Kim HI; Kim TH; Choe JH; Kim JH; Kim JS; Oh YL; Hahn SY; Shin JH; Jang HW; Kim YN; Kim H; Ahn HS; Kim K; Kim SW; Chung JH
    Cancer Med; 2017 Oct; 6(10):2244-2251. PubMed ID: 28857489
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risk factors for level V lymph node metastases in solitary papillary thyroid carcinoma with clinically lateral lymph node metastases.
    Yang J; Gong Y; Yan S; Zhu J; Li Z; Gong R
    Cancer Med; 2016 Aug; 5(8):2161-8. PubMed ID: 27368106
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multifocality, but not bilaterality, is a predictor of disease recurrence/persistence of papillary thyroid carcinoma.
    Kim HJ; Sohn SY; Jang HW; Kim SW; Chung JH
    World J Surg; 2013 Feb; 37(2):376-84. PubMed ID: 23135422
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Skip lateral lymph node metastasis leaping over the central neck compartment in papillary thyroid carcinoma.
    Lei J; Zhong J; Jiang K; Li Z; Gong R; Zhu J
    Oncotarget; 2017 Apr; 8(16):27022-27033. PubMed ID: 28223546
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinicopathologic characteristics and pattern of central lymph node metastasis in papillary thyroid cancer located in the isthmus.
    Lee YC; Na SY; Chung H; Kim SI; Eun YG
    Laryngoscope; 2016 Oct; 126(10):2419-21. PubMed ID: 27098428
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Predictors of level V lymphatic metastasis in papillary thyroid carcinoma].
    Chen R; Wei T; Li ZH; Gong RX; Zhu JQ
    Zhonghua Wai Ke Za Zhi; 2012 Jul; 50(7):625-8. PubMed ID: 22943994
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of the clinicopathologic features and prognosis of bilateral versus unilateral multifocal papillary thyroid cancer: An updated study with more than 2000 consecutive patients.
    Wang W; Su X; He K; Wang Y; Wang H; Wang H; Zhao Y; Zhao W; Zarnegar R; Fahey TJ; Teng X; Teng L
    Cancer; 2016 Jan; 122(2):198-206. PubMed ID: 26506214
    [TBL] [Abstract][Full Text] [Related]  

  • 56. BRAF V600E does not predict aggressive features of pediatric papillary thyroid carcinoma.
    Givens DJ; Buchmann LO; Agarwal AM; Grimmer JF; Hunt JP
    Laryngoscope; 2014 Sep; 124(9):E389-93. PubMed ID: 24604709
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Well-differentiated thyroid carcinoma with concomitant Hashimoto's thyroiditis present with less aggressive clinical stage and low recurrence.
    Huang BY; Hseuh C; Chao TC; Lin KJ; Lin JD
    Endocr Pathol; 2011 Sep; 22(3):144-9. PubMed ID: 21647844
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risk factors of central lymph node metastasis of papillary thyroid carcinoma: A single-center retrospective analysis of 3273 cases.
    Liu W; Cheng R; Su Y; Diao C; Qian J; Zhang J; Ma Y; Fan Y
    Medicine (Baltimore); 2017 Oct; 96(43):e8365. PubMed ID: 29069024
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Implications of Extrathyroidal Extension Invading Only the Strap Muscles in Papillary Thyroid Carcinomas.
    Li G; Li R; Song L; Chen W; Jiang K; Tang H; Wei T; Li Z; Gong R; Lei J; Zhu J
    Thyroid; 2020 Jan; 30(1):57-64. PubMed ID: 31830859
    [No Abstract]   [Full Text] [Related]  

  • 60. Altered expression of estrogen receptor β2 is associated with different biological markers and clinicopathological factors in papillary thyroid cancer.
    Dong W; Li J; Zhang H; Huang Y; He L; Wang Z; Shan Z; Teng W
    Int J Clin Exp Pathol; 2015; 8(6):7149-56. PubMed ID: 26261608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.